Published in Medical Letter on the CDC and FDA, August 22nd, 2004
According to a study from the United States, "Rapid HIV antibody tests (RT) now permit HIV screening in settings where laboratory personnel may not be available. This study assessed the ability of 99 individuals with no laboratory experience to conduct two RT, OraQuick and Hema-Strip; these results were compared with those generated by laboratory professionals. All participants received written instructions and one-half also received a short demonstration."
"Error rates ranged from 2.1% to 4.6% with or without a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.